CLINICAL_TRIALS ClinicalTrials.gov record update

A Clinical Trial of Pembrolizumab (MK-3475) Evaluating Predictive Biomarkers in Subjects With Advanced Solid Tumors (KEYNOTE 158)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02628067
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:17.368083+00:00
Published At: 2025-09-22T00:00:00+00:00
Record Updated At: 2025-09-22
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Advanced Cancer", "Anal Carcinoma", "Anal Cancer", "Biliary Cancer", "Cholangiocarcinoma", "Bile Duct Cancer", "Neuroendocrine Tumor", "Carcinoid Tumor", "Endometrial Carcinoma", "Endometrial Cancer", "Cervical Carcinoma", "Cervical Cancer", "Vulvar Carcinoma", "Vulvar Cancer", "Small Cell Lung Carcinoma", "Small Cell Lung Cancer (SCLC)", "Mesothelioma", "Thyroid Carcinoma", "Thyroid Cancer", "Salivary Gland Carcinoma", "Salivary Gland Cancer", "Salivary Cancer", "Parotid Gland Cancer", "Advanced Solid Tumors", "Colorectal Carcinoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-09-22"
protocolSection.identificationModule.nctId: "NCT02628067"
protocolSection.identificationModule.officialTitle: "A Clinical Trial of Pembrolizumab (MK-3475) Evaluating Predictive Biomarkers in Subjects With Advanced Solid Tumors (KEYNOTE 158)"
protocolSection.statusModule.overallStatus: "ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.